Viewing nowCombinationHanol Neo Fortis 5/160mg
Valsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Hanol Bio Pharma Co., Ltd.

MFDS item code 201308544 · Approved 2013.07.30 · Insurance code 655605560
Treatment of essential hypertension not controlled with monotherapy
This medication is used to effectively lower blood pressure in patients with essential hypertension whose blood pressure is insufficiently controlled by monotherapy with amlodipine or valsartan.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows. ㆍ 5/80 mg: For patients whose blood pressure is not adequately controlled with monotherapy using amlodipine 5 mg or valsartan 80 mg. ㆍ 5/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy using amlodipine 5 mg or valsartan 160 mg. ㆍ 10/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy using amlodipine 10 mg or valsartan 160 mg, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a fixed-dose combination containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or more); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Caution should be exercised when increasing the dose.
The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.
This medication can cause serious harm to the fetus and newborn if taken during the second or third trimester of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to the active ingredients or similar drugs, women who are pregnant or breastfeeding, patients with severe kidney or liver dysfunction, and patients with certain heart diseases should not take this medication. Patients who are deficient in sodium or fluids should correct their condition before taking this medication, and careful observation is required during the initial administration due to potential hypotension symptoms. Patients with high potassium levels or those taking other medications that may increase potassium levels should have their potassium levels checked frequently. Patients with renal vascular issues or those who have recently received a kidney transplant should use this medication with caution as it may affect kidney function. If symptoms of angioedema such as swelling of the face, lips, or tongue occur, discontinue use immediately and do not resume. Patients with heart failure or after a myocardial infarction may experience changes in kidney function while taking this medication, hence regular monitoring of kidney function is necessary. Overdosing on this medication can lead to hypotension or irregular heartbeats, so immediate medical attention is required if an overdose occurs. Dizziness or fatigue may occur while driving or operating machinery, so caution is advised, especially upon initial use or dosage adjustments. This medication may interact with other antihypertensives, potassium supplements, and non-steroidal anti-inflammatory drugs (NSAIDs), so consult a doctor or pharmacist if other medications are being taken. Women who are pregnant or planning to become pregnant should not take this medication, and breastfeeding women should also avoid this medication. Safety and efficacy in pediatric patients under 18 years of age have not been established, so use is not recommended. Elderly patients may use the same dosages as adults, but need to be monitored closely depending on their condition. Regular liver function tests or kidney function tests during treatment with this medication are recommended, and any unusual symptoms should be reported to medical personnel immediately.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to avoid exposure to air and moisture. Additionally, it is best kept at room temperature between 1 degree and 30 degrees Celsius. This will help maintain the medication's effectiveness over time.
Dark yellow oval film-coated tablets
PTP - 28 tablets/box[(14 tablets/PTP packaging×2)], bottle - 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Hanol Bio Pharma Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.